Standard Biotools (LAB) Other Non Operating Income (2010 - 2026)

Standard Biotools (LAB) has 17 years of Other Non Operating Income data on file, last reported at -$5.6 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income fell 1092.95% year-over-year to -$5.6 million in Q1 2026; TTM through Mar 2026 was -$4.7 million, a 84.02% increase from a year earlier, with the FY2025 full-year figure at $4.4 million, up 187.74% from the prior year.
• Other Non Operating Income for Q1 2026 stood at -$5.6 million, down from $956000.0 in the prior quarter.
• Over the last five years, Other Non Operating Income for LAB reached as high as $1.1 million in Q1 2023 and fell as low as -$30.2 million in Q4 2024.
• Historically, Other Non Operating Income has averaged -$3.3 million across 5 years, with a median of -$63000.0 in 2022.
• Across the five-year window, Other Non Operating Income surged 857.63% in 2023 and slumped 1092.95% in 2026, its largest moves.
• Year by year, Other Non Operating Income stood at -$699000.0 in 2022, then surged by 261.66% to $1.1 million in 2023, then tumbled by 2774.42% to -$30.2 million in 2024, then soared by 103.16% to $956000.0 in 2025, then slumped by 688.91% to -$5.6 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were -$5.6 million in Q1 2026, $956000.0 in Q4 2025, and $567000.0 in Q1 2025.